scholarly article | Q13442814 |
P50 | author | Nicolas A Stewart | Q42758600 |
P2093 | author name string | Thomas P Conrads | |
Robert A Branch | |||
Shama C Buch | |||
P2860 | cites work | Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail". | Q44637323 |
Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach | Q45278849 | ||
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail". | Q51373538 | ||
Determination of a 'GW cocktail' of cytochrome P450 probe substrates and their metabolites in plasma and urine using automated solid phase extraction and fast gradient liquid chromatography tandem mass spectrometry. | Q51432740 | ||
Metabolism of drugs and carcinogens by human liver enzymes | Q68717160 | ||
Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a "cocktail" study design | Q69615072 | ||
High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans | Q71722771 | ||
Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes | Q73846452 | ||
Liver disease selectively modulates cytochrome P450--mediated metabolism | Q80212249 | ||
Validation of incorporating flurbiprofen into the Pittsburgh cocktail | Q80212255 | ||
In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model | Q31520211 | ||
Summary of information on human CYP enzymes: human P450 metabolism data | Q32103802 | ||
Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach | Q34418061 | ||
Cytochromes P450 in the bioactivation of chemicals | Q35972701 | ||
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach | Q36720920 | ||
Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using Cyp2e1(-/-) mice | Q36990035 | ||
Cytochrome P450-activated prodrugs: targeted drug delivery. | Q37294258 | ||
Molecular modeling of cytochrome P450 and drug metabolism | Q37743544 | ||
A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans | Q37946157 | ||
P450 genes: structure, evolution, and regulation | Q39664988 | ||
The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature | Q40484461 | ||
The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes. | Q44481060 | ||
P4510 | describes a project that uses | stable isotope | Q878130 |
P433 | issue | 3 | |
P921 | main subject | stable isotope | Q878130 |
P304 | page(s) | 605-612 | |
P577 | publication date | 2010-11-25 | |
P1433 | published in | Analyst | Q969812 |
P1476 | title | A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution | |
P478 | volume | 136 |
Q92193026 | Analytical Methods for Mass Spectrometry-Based Metabolomics Studies |
Q37034724 | Effect of Repeated Wuniu Early Tea Administration on the CYP450 Activity Using a Cocktail Method |
Q57157647 | Effect of caffeine on adenosine-induced reversible perfusion defects assessed by automated analysis |
Q47782012 | Effects of vitexin on the pharmacokinetics and mRNA expression of CYP isozymes in rats |
Q38769103 | Emerging applications of metabolomics in drug discovery and precision medicine |
Q39508644 | Quantifying four-probe metabolites in a single UPLC-MS/MS run to explore the effects of cooked rhubarb on cytochrome P450 isozymes |
Q40643491 | Rapid and accurate liquid chromatography and tandem mass spectrometry method for the simultaneous quantification of ten metabolic reactions catalyzed by hepatic cytochrome P450 enzymes |
Q51431632 | Rapid and on-site analysis of illegal drugs on the nano-microscale using a deep ultraviolet-visible reflected optical fiber sensor. |
Q41737190 | Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers. |
Search more.